Analysis of the steady-state relations and control-algorithm characterisation in a mathematical model of cholesterol biosynthesis
暂无分享,去创建一个
Ales Belic | Jure Acimovic | Marko Golicnik | Adviti Naik | Jure Acimovic | A. Belic | A. Naik | M. Goličnik
[1] Joachim Selbig,et al. Metabolic networks are NP-hard to reconstruct. , 2008, Journal of theoretical biology.
[2] Jason A. Papin,et al. The genome-scale metabolic extreme pathway structure in Haemophilus influenzae shows significant network redundancy. , 2002, Journal of theoretical biology.
[3] Joze Drinovec,et al. Modeling the influence of risk factors and chronic diseases on the development of strokes and peripheral arterial-vascular disease , 2008, Simul. Model. Pract. Theory.
[4] M. Mavrovouniotis. Estimation of standard Gibbs energy changes of biotransformations. , 1991, The Journal of biological chemistry.
[5] Peter J Espenshade,et al. Regulation of sterol synthesis in eukaryotes. , 2007, Annual review of genetics.
[6] Tatsuhiko Kodama,et al. Sterol-dependent Transcriptional Regulation of Sterol Regulatory Element-binding Protein-2* , 1996, The Journal of Biological Chemistry.
[7] G. Stephanopoulos,et al. Computer‐aided synthesis of biochemical pathways , 1990, Biotechnology and bioengineering.
[8] Katsuhiko Ogata,et al. Modern Control Engineering , 1970 .
[9] S. Baker,et al. Clinical perspectives of statin-induced rhabdomyolysis. , 2006, The American journal of medicine.
[10] J E Mittenthal,et al. A new method for assembling metabolic networks, with application to the Krebs citric acid cycle. , 2001, Journal of theoretical biology.
[11] Marc K Hellerstein,et al. A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control: advantages of pathway-based discovery. , 2008, Metabolic engineering.
[12] Chunhui Li,et al. Exploring the diversity of complex metabolic networks , 2005, Bioinform..
[13] K. Monostory,et al. Perspectives of the non-statin hypolipidemic agents. , 2010, Pharmacology & therapeutics.
[14] Nico Van de Veire. European Cardiovascular Disease Statistics 4 th edition 2012 : EuroHeart II , .
[15] Jotun Hein,et al. A stochastic model for the evolution of metabolic networks with neighbor dependence , 2009, Bioinform..
[16] Naresh K. Sinha,et al. Modern Control Systems , 1981, IEEE Transactions on Systems, Man, and Cybernetics.
[17] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[18] I. Goryanin,et al. Human metabolic network reconstruction and its impact on drug discovery and development. , 2008, Drug discovery today.
[19] Joze Drinovec,et al. Simulation analysis of coronary heart disease, congestive heart failure and end-stage renal disease economic burden , 2011, Math. Comput. Simul..
[20] Uroš Urleb,et al. Inhibition of Human Sterol Δ7-Reductase and Other Postlanosterol Enzymes by LK-980, a Novel Inhibitor of Cholesterol Synthesis , 2011, Drug Metabolism and Disposition.
[21] Mark Gerstein,et al. Training set expansion: an approach to improving the reconstruction of biological networks from limited and uneven reliable interactions , 2008, Bioinform..
[22] Linda J. Broadbelt,et al. Computational discovery of biochemical routes to specialty chemicals , 2004 .
[23] Maja Atanasijević-Kunc,et al. MODELLING OF THE RISK FACTORS AND CHRONIC DISEASESTHAT INFLUENCE THE DEVELOPMENT OF SERIOUS HEALTHCOMPLICATIONS , 2008 .